OneMedNet (NASDAQ:ONMD) CFO Sells 3,000 Shares of Company Stock

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Lawrence Golden sold 3,000 shares of OneMedNet stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $6.30, for a total transaction of $18,900.00. Following the completion of the sale, the chief financial officer directly owned 94,291 shares of the company’s stock, valued at approximately $594,033.30. The trade was a 3.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Monday, September 21st, Robert Lawrence Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.63, for a total value of $19,890.00.

OneMedNet Price Performance

Shares of ONMD stock traded down $0.52 on Friday, hitting $4.30. The stock had a trading volume of 24,653 shares, compared to its average volume of 69,105. OneMedNet Corporation has a 12-month low of $4.30 and a 12-month high of $42.20. The business has a 50 day moving average of $6.24 and a 200 day moving average of $7.32. The stock has a market cap of $25.50 million, a price-to-earnings ratio of -2.69 and a beta of 1.14.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, OneMedNet has an average rating of “Sell”.

About OneMedNet

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.